These CYP enzymes’ polymorphisms have been suggested to modulate the cancer risk of patients and contribute to individual susceptibility, particularly in the metabolism of tobacco-related compounds (Hernando-Rodriguez et al., 2012). Here, PPIG is linked to cancer.